Artur Burger

Title: Artur Burger: Innovator in Pharmaceutical Modifications

Introduction

Artur Burger is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative modifications of existing compounds. With a total of 2 patents, Burger's work has the potential to enhance the stability and formulation of important medications.

Latest Patents

Among his latest patents is a new modification of Lifibrol, which is described as having a melting point ranging from 132°C to 138°C, particularly between 134°C and 136°C. This modification is characterized by a primary peak in its IR spectrum at a wave number of 3,200-3,400, preferably at 3,250-3,350. The new modification, referred to as modification II, allows for good crystallization, making it suitable for large-scale industrial formulation into tablets that are both stable and of acceptable size. Another significant patent involves soft elastic gelatin capsules containing primarily the crystalline form A of oxytetracycline hydrochloride, which exhibit increased storage ability.

Career Highlights

Throughout his career, Artur Burger has worked with reputable companies in the pharmaceutical industry, including R.P. Scherer Corporation and Klinge Pharma GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Artur has collaborated with several professionals in his field, including Werner Brox and Anita Lettenbichler. These collaborations have likely enriched his work and led to advancements in his research.

Conclusion

Artur Burger's contributions to pharmaceutical innovations, particularly through his patents on Lifibrol and oxytetracycline capsules, demonstrate his commitment to improving medication stability and formulation. His work continues to impact the pharmaceutical industry positively.